Objective To explore the clinical characteristics and treatment of neonatal methylmalonic academia(MMA). Method The clinical data of 7 patients with neonatal MMA were analyzed and the diagnoses were confirmed by gas chromatography-mass spectrometry(GC/MS). Results The patients consisted of 3 males and 4 females, whose age of onset ranged from 0 to 6 days with all 7 cases early in the first week after birth.The main clinical manifestations were weak reaction(6 cases), poor feeding(7 cases), hyperpnea(3 cases), convulsion(2 cases), hypotonia(7 cases), et al.6 cases presented with thrombocytopenia.The laboratory findings showed metabolic acidosis in 6 cases, hyperammonemia in 4 cases and remarkable elevation of urinary methylmalonicacid concentration in all cases.Some abnormalities were noted by the brain CT or MR in 2 cases of 5.2 cases died at a short time after giving up therapy, 1 case died at the age of 3-month after giving up therapy, 1 case follow-up failed to.2 cases received therapy of vitamin B12 and supplementation of L-carnitine with restricted-protein diet and showed a favorable outcome with no symptoms for a period ranging from 1 year to 1 years and 9 months.1 case received therapy of vitamin B12 and supplementation of L-carnitine with restricted-protein diet, but no effect and died at the age of 4-month. Conclusions The clinical manifestations of neonatal MMA are nonspecific.GC/MS can be used to confirm the diagnosis.Early diagnosis and early treatment is the key to improve the prognosis.
Key words
methylmalonic acid /
vitamin B12 /
mass fragmentography
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] Han LS, Ye J, Qiu WJ, et al.Selective screening for inborn errors of metabolism on clinical patients using tandem mass spectrometry in China:a four-year report[J].J Inherit Metab Dis, 2007, 30:507-514.
[2] Hzrster F, Hoffmann GF.Pathophysiology, diagnosis, and treat-ment of methylmalonic aciduria:recent advances and new chal-lenges[J].Pediatr Nephrol, 2004, 19(10):1071-1074.
[3] 罗小平.有机酸代谢障碍[M]// 左启华.小儿神经系统疾病.2版.北京:人民卫生出版社, 2003:484-487.
[4] Rossi A, Cerone R, Biancheri R, et al.Early-onset combined methylmalonic aciduria and homocystinuria:neuroradiologic findings[J].AJNR Am J Neuroradiol, 2001, 22(3):554-563.
[5] 封志纯.新生儿遗传代谢病早期识别[J].中国新生儿杂志, 2009, 24(4):328-330.
[6] 肖江喜.磁共振成像[M]//左启华.小儿神经系统疾病.2版.北京:人民卫生出版社, 2002:123-178.
[7] 常平, 朱德新, 胡艳群, 等.连续血液净化治疗先天性代谢缺陷病重症有机酸血症[J].小儿急救医学, 2004, 11(6):380-383.
[8] Yannicelli S, Acosta PB, Velazquez A, et al.Improved growth and nutrition status in children with methylmalonic or propionic acidemia fed an elemental medical food[J].Mol Genet Metab, 2003, 80(1-2):181-188.
[9] De Baulny HO, Benoist JF, Rigal O, et al.Methylmalonic and ropionic acidemias:management and outcome[J].Inherit Etab Dis, 2005, 28(3):415-423.
[10] Jones PM, Bannett MJ.The changing face of newborn screening:diagnosis of inborn errors of metabolism by tandem mass spec-trometry[J].Clin Chim Acta, 2002, 324(1-2):121-128.
PDF(445 KB)
